期刊文献+

桉柠蒎的药理作用与临床评价 被引量:47

An evaluation on pharmacologic effect and clinical application of eucalyptol-limonene-pinene enteric soft capsule
下载PDF
导出
摘要 目的评价桉柠蒎的药理作用及临床应用。方法收集和查找文献资料,从药理作用、药动学、国内外临床研究、用法与用量、药物不良反应5个方面全面评价桉柠蒎。结果详细地评价了桉柠蒎的作用机理及临床应用。结论桉柠蒎是粘液溶解性祛痰药,可解除粘液纤毛清除系统障碍,全面恢复粘液纤毛清除系统功能,重建整个系统的清除防御机制,打破炎症的恶性循环,从根本上治疗鼻炎、支气管炎等气道炎性反应。 Objective To evaluate the pharmacologic effects and clinical application of eucalyptol-limonene-pinene (ELP) enteric soft capsule. Methods Based on data from literatures, overall assessment was made in terms of pharmacologic effects, pharmacokinetics, domestic and abroad clinical research, direction and dosage, and drug adverse reaction of ELP enteric soft capsule. Results An detailed evaluation was given. Conclusions ELP enteric soft capsule is a kind of expectorants with mucolysis effects, and can relief the obstacles in mucus cilium scavenging system, recover the system function, and rebuild the defence comprtence. In this way, it can break the infernal circle of inflammation, and cure inflammation of air duct such as rhinitis, and bronchitis.
出处 《中国现代药物应用》 2008年第24期26-28,共3页 Chinese Journal of Modern Drug Application
关键词 桉柠蒎 清除 粘液纤毛 ELP enteric soft capsule Scavenge Mucus cilium
  • 相关文献

参考文献9

  • 1[2]Matzke H.Experiences with Gelomyrtol in the treatment of bronchitis.Munch Med Wochenschr,1961,29(103):1881-1882.
  • 2[3]Kurz JF.Secretolysis through gelomyrtol.Z Allgemeinmed,1970,46(32):1623-1627.
  • 3[4]Straehler Pohl HJ,Burmeister G.Use of Gelomyrtol forte in sinusitides.ZFA (Stuttgart),1978,54(10):611-615.
  • 4[5]Dorow P,Weiss T,Felix R,et al.Effect of a secretolytic and a combination of pinene,limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease.Arzneimittelforschung,1987,37(12):1378-1381.
  • 5[6]Ulmer WT,Schott D.Chronic obstructive bronchitis.Effect of Gelomyrtol forte in a placebo-controlled double-blind study.Fortschr Med,1991,109(27):547-550.
  • 6[7]Sengespeik HC,Zimmermann T,Peike C,et al.Myrtol standardized in the treatment of acute and chronic respiratory infections in children.Arzneimittelforschung,1998,48(10):990-994.
  • 7[8]Meister R,Wittig T,Beuscher N,de Mey C.Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis.A double-blind,placebo-controlled study.Study Group Investigators.Arzneimittelforschung,1999,49 (4):351-358.
  • 8[9]Matthys H,de Mey C,Carls C,et al.Efficacy and tolerability of myrtol standardized in acute bronchitis.Arzneimittelforschung,2000,50(8):700-711.
  • 9付文卫,赵春杰,窦德强,裴玉萍,王瑞杰,陈英杰.标准桃金娘油药理及临床研究进展[J].中成药,2003,25(12):1009-1012. 被引量:24

二级参考文献14

  • 1Straehler-Pohl HJ, Burmeister G. Use of Gelomyrtol forte in sinusitides A course study[J]. ZFA (Stuttgart). 1978, Apr 54:611-615.
  • 2Federspil P, Wulkow R, Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis-results of a double-blind,randomized multicenter study compared with placebo[J]. Laryngorhinootologie. 1997, 76:23-27.
  • 3Matthys H, De Mey C, Carls C, et al. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. Cefuroxime and ambroxol[ J ]. Arzneimittelforschung,2000, 50:700-711.
  • 4Meister R, Witting T, Beuscher N, et al. Efficacy and Tolerability of Myrtol Standardized in Long-term Treatment of Chronic Bronchitis. A double-blind, placebo-controlled study. Study Group Investigators[J]. Arzneimttelforsc-hung, 1999, 49:351-358.
  • 5Ulmer WT, Scha D. Chronic obstructive bronchitis. Effect of Gelomrtol forte in a placebo-controlled double-blind study[J ].Fortschr Med. 1991, 109:547-550.
  • 6Sengespeik HC, Zimmermann T, Peiske C, et al. Myrtol Standardized in the Treatment of Acute and Chronic Respiratory Infections in Children/A multicenter postmarketing surveillance study[J]. Arzneimittelforsc-hung, 1998, 48:990-994.
  • 7Dorow P, Weiss Th, Felix R, et al. Effect of a Secretolytic and a Combination of Pinene, Limonene and Cineole on Mucociliary Clearance in Patients with Chronic Pulmonary Obstruction[J].Arzneim Forsch, 1987, 37:1378-1381.
  • 8Zimmermann Th, Seiberling M, Thomann P, et al. Evaluation of the Relative Bioavailability and the Pharmacokinetics of Myrtol Standardized[J]. Arzneim Forsch, 1995, 45 : 1198-1201.
  • 9Uehleke H, Brinkschulte-Freitas M. Oral toxicity of an essential oil from myrtle and adaptive liver stimulation[ J ]. Toxicology,(1979) 12(3) :335-342.
  • 10Gall H, Kaehler A, Peter RU. Anaphylactic shock reaction to dibutyl-phthalate-containing capsules[J]. Dermatology, 1999,199:169-170.

共引文献23

同被引文献315

引证文献47

二级引证文献224

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部